| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $20.38B | $20.10B | $19.46B |
| YoY Revenue Growth % | +1.4% | +3.3% | — |
| Gross Profit | $12.25B | $12.16B | — |
| Gross Margin % | 60.1% | 60.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $3.31B | $4.27B | $3.98B |
| Operating Margin % | 16.2% | 21.2% | 20.5% |
| Net Income (GAAP) | $2.13B | $2.89B | $2.30B |
| EBITDA (Normalized) | $4.04B | $4.99B | $4.68B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $4.20B | $4.11B | $3.75B |
| Capital Expenditures (CapEx) | $917.2M | $904.5M | $875.6M |
| Free Cash Flow (FCF) | $3.28B | $3.20B | $2.87B |
| FCF Margin % | 16.1% | 15.9% | 14.7% |
| Return on Invested Capital (ROIC %) | 46.3% | 52.6% | 12.8% |
| Cash & Short-Term Equivalents | $1.29B | $1.10B | — |
| Total Debt (Short + Long Term) | $6.87B | $7.29B | $9.56B |
| Total Stockholders' Equity | $54.0M | $212.0M | $19.61B |